Transdermal drug delivery device
US10953211B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 18, 2018 |
| Grant date | Mar 23, 2021 |
| Priority date | — |
| Expiry date | Mar 20, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2037/0061
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A transdermal drug delivery device is disclosed that may comprise a housing including an upper housing portion and a lower housing portion. The lower housing portion may define a bottom surface including skin attachment means for releasably attaching the lower housing portion to skin of a user. The upper housing portion may at least partially surround a central region of the device. The device may also include a microneedle assembly and a reservoir disposed within the central region. The reservoir may be in fluid communication with the microneedle assembly. Additionally, the device may include a pushing element disposed above the microneedle assembly within the central region. The pushing element may be configured to provide a continuous bilateral force having a downward component transmitted through the microneedle assembly and an upward component transmitted through the skin attachment means.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.